Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects

Epidemiology

Volumn 6, Issue 3, 1995, Pages 219-226

  Shaw, Gary M ^a   Schaffer, Donna ^b   Velie, Ellen M ^a   Morland, Kimberly ^a   Harris, John A ^a  

^a Division of Research ^*  (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

Anencephaly; Birth defects; Case control study; Folate; Spina bifida; Vitamins

Indexed keywords

FOLIC ACID; MULTIVITAMIN;

ADULT; ANENCEPHALUS; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIETARY INTAKE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SPINA BIFIDA; VITAMIN INTAKE;

ADULT; CALIFORNIA; CASE-CONTROL STUDIES; DEMOGRAPHY; DIET; ENERGY INTAKE; ETHNIC GROUPS; FEMALE; FOLIC ACID; HUMAN; INFANT, NEWBORN; INTERVIEWS; NEURAL TUBE DEFECTS; ODDS RATIO; PRECONCEPTION CARE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RISK FACTORS; VITAMINS;

EID: 0028962102     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/00001648-199505000-00005     Document Type: Article

References (41)

1. Khoury MJ, Erickson JD, James LM. Etiologic heterogeneity of neural tube defects: clues from epidemiology. Am J Epidemiol 1982;115:538–548.
2. Holmes LB, Driscoll SG, Atkins L. Etiologic heterogeneity of neural-tube defects. N Engl J Med 1976;294:365–369.
3. Elwood JM, Little J, Elwood JH. Epidemiology and Control of Neural Tube Defects. Monographs in Epidemiology and Biostatistics, vol. 20. Oxford: Oxford University Press, 1992.
4. Campbell LR, Dayton DH, Sohal GS. Neural tube defects: a review of human and animal studies on the etiology of neural tube defects. Teratology 1986;34:171–187.
5. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child 1976;51:944–950.
6. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Doubleblind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J 1981;282:1509–1511.
7. Seller MJ, Nevin NC. Periconceptional vitamin supplementation and the prevention of neural tube defects in south-east England and Northern Ireland. J Med Genet 1984;21:325–330.
8. Smithells RW, Seller MJ, Harris R, Fielding DW, Schorah CJ, Nevin NC, Sheppard S, Read AP, Walker S, Wild J. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983;1:1027–1031.
9. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP, Fielding DW. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 1981;56:911– 918.
10. Vergel RG, Sánchez LR, Heredero BL, Rodriguez PL, Martinez AJ. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 1990;10:149–152.
11. Holmes-Siedle M, Lindenbaum RH, Galliard A, Bobrow M. Vitamin supplementation and neural tube defects. Lancet 1982;1:276.
12. Medical Research Council Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 1991;338:131–137.
13. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327: 1832–1835.
14. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260: 3141–3145.
15. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989;150;5:613–619.
16. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257–1261.
17. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847–2852.
18. Mills JL, Rhoads GG, Simpson JL, Cunningham GC, Conley MR, Lassman MR, Walden ME, Depp DR, Hoffman HJ. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. N Engl J Med 1989;321:430–435.
19. Centers for Disease Control. Use of folic acid for prevention of spina bifida and other neural tube defects–1983–1991. MMWR 1991;40:513–515.
20. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992;41:1–7.
21. From the Food and Drug Administration. JAMA 1993;270:2283.
22. Sever LE. An epidemiologic study of neural tube defects in Los Angeles County. II. Etiologic factors in an area with low prevalence at birth. Teratology 1982;25:323–334.
23. Croen LA, Shaw GM, Jensvold NJ, Harris JA. Birth defects monitoring in California: a resource for epidemiological research. Paediatr Perinat Epidemiol 1991;5:423–427.
24. Spranger J, Benirschke K, Hall JG, Lenz W, Lowry RB, Opitz JM, Pinsky L, Schwanacher HG, Smith DW. Errors of morphogenesis: concepts and terms: recommendations of an international working group. J Pediatr 1982; 100: 160–165.
25. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453–469.
26. EGRET. Version 0.25.6. Seattle: Statistics and Epidemiology Research Corporation, 1991.
27. Shaw GM, Jensvold NJ, Wasserman CR, Lammer EJ. Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983–87. Teratology 1994;49:143–149.
28. Viral Statistics of California 1985. Sacramento: State of California Health and Welfare Agency, Department of Health Services, 1987.
29. Vital Statistics of California 1986. Sacramento: State of California Health and Welfare Agency, Department of Health Services, 1987.
30. Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977; 105:488–495.
31. Swan SH, Shaw GM, Schulman J. Reporting and selection bias in case-control studies of congenital malformations. Epidemiology 1992;3:356–363.
32. Hook EB. Neural tube rupture as a cause of neural tube defects. Lancet 1992;339:1000.
33. Block G. A review of validations of dietary assessment methods. Am J Epidemiol 1982;115:492–505.
34. Willett W. Nutritional Epidemiology. Oxford: Oxford University Press, 1990.
35. Medlin C, Skinner JO. Individual dietary intake methodology: a fifty year review of progress. J Am Diet Assoc 1988;88:1250–1257.
36. Mares-Perlman JA, Klein BE, Klein R, Ritter LL, Fisher MR, Freudenheim JL. A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. J Nutr 1993;123: 489–501.
37. Block G, Thompson FE, Hartman AM, Larkin FA, Guire KE. Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 1992;92:686-693.
38. Block G, Woods M, Potosky A, Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990;43:1327–1335.
39. Block G, Subar AF. Estimates of nutrient intake from a food frequency questionnaire: the 1987 National Health Interview Survey. J Am Diet Assoc 1992;92:969–977.
40. Sauberlich HE, Kretsch MJ, Skala JH, Johnson HL, Taylor PC. Folate requirement and metabolism in non-pregnant women. Am J Clin Nutr 1987;46:1016–1028.
41. Keagy PM, Shane B, Oace SM. Folate bioavailability in humans: effects of wheat bran and beans. Am J Clin Nutr 1988;47:80–88.